1. Home
  2. HCPCS Crosswalk
  3. HCPCS J2354

HCPCS J2354

Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg

Table of Contents

  1. HCPCS Information
  2. HCPCS Crossover to NDC Codes

HCPCS Information

HCPCS Code: J2354
The Healthcare Common Procedure Coding System (HCPCS) is a set of unique alphanumeric codes used to report medical procedures and services to healthcare programs like Medicare and Medicaid. HCPCS codes are used in conjunction with NDC codes for billing and medical documentation puporses. For instance, HCPCS J2354 identifies the type of service or supply used while any of the 35 NDC codes below could be used to specify the exact drug used.
Short Description
Octreotide inj, non-depot
Long Description
Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg
Pricing Indicator
Drugs
Multiple Pricing Indicator
Not applicable as HCPCS priced under one methodology
Coverage Description
Carrier judgment
BETOS Type of Service
Other drugs
Medicare Payment Limit
$0.62
Medicare Co-Insurance Percentage
20.000%
HCPCS Classification
List of HCPCS codes for: Drugs Administered Other Than Oral Method, Chemotherapy Drugs (J-codes)

HCPCS Crossover to NDC Codes

The NDC codes below allow precise billing based on the specific manufacturer and medication used:

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0078-0180Sandostatin Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousNovartis Pharmaceuticals CorporationACTIVE
0078-0181Sandostatin Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousNovartis Pharmaceuticals CorporationACTIVE
0078-0182Sandostatin Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousNovartis Pharmaceuticals CorporationACTIVE
0641-6174Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0641-6175Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0641-6176Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0641-6177Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0641-6178Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0703-3301Octreotide Acetate Teva Parenteral Medicines, Inc.
0703-3311Octreotide Acetate Teva Parenteral Medicines, Inc.
0703-3321Octreotide Acetate Teva Parenteral Medicines, Inc.
0703-3321Octreotide Acetate Teva Parenteral Medicines, Inc.
0703-3333Octreotide Acetate Teva Parenteral Medicines, Inc.
0703-3343Octreotide Acetate Teva Parenteral Medicines, Inc.
23155-685Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; IntravenousHeritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.ACTIVE
23155-686Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHeritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.ACTIVE
23155-687Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHeritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.ACTIVE
23155-688Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHeritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.ACTIVE
23155-689Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousHeritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.ACTIVE
25021-463Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
25021-464Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
25021-465Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
25021-466Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
25021-467Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
63323-376Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63323-376Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63323-377Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63323-377Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63323-378Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
63323-379Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
68462-896Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousGlenmark Pharmaceuticals Inc., UsaACTIVE
68462-897Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousGlenmark Pharmaceuticals Inc., UsaACTIVE
71288-566Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousMeitheal Pharmaceuticals, Inc.ACTIVE
71288-567Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousMeitheal Pharmaceuticals, Inc.ACTIVE
71288-568Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousMeitheal Pharmaceuticals, Inc.ACTIVE